Interleukin Genetics Appoints Global Clinical Advisory Board To Guide Enhanced Healthcare through Targeted Management of Systemic ...
WALTHAM, Mass., March 16, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic diseases that reduce longevity and life quality, today announced …